Mesoblast (MESO) Income towards Parent Company (2015 - 2023)

Mesoblast (MESO) reported Income towards Parent Company of -$142.2 million for Q2 2023, up 11.57% on a YoY basis from -$127.5 million in Q2 2022, and down 862.86% sequentially from $18.6 million in Q1 2023.

Mesoblast (MESO) Income towards Parent Company (2015 - 2023) Analysis & Trends

Mesoblast (MESO) has 9 years of Income towards Parent Company data on file, last reported at -$142.2 million in Q2 2023.

  • For the quarter ending Q2 2023, Income towards Parent Company rose 11.57% year-over-year to -$142.2 million; the trailing twelve-month figure through Dec 2024 stood at -$142.2 million (down 43.62% YoY), and the FY2025 full-year result was -$102.1 million, down 16.13% from the prior year.
  • Income towards Parent Company declined to -$142.2 million in Q2 2023, from $18.6 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $24.6 million in Q4 2022 to a low of -$160.9 million in Q2 2022.
  • A 5-year average of -$26.7 million and a median of -$23.6 million in 2020 frame the typical range for Income towards Parent Company.
  • Peak annual rise in Income towards Parent Company reached 194.65% in 2022, while the deepest fall reached 629.19% in 2022.
  • Tracing MESO's Income towards Parent Company over 5 years: stood at -$24.6 million in 2019, then slipped by 4.51% to -$25.7 million in 2020, then retreated by 0.98% to -$25.9 million in 2021, then soared by 194.65% to $24.6 million in 2022, then slumped by 679.24% to -$142.2 million in 2023.
  • Business Quant data shows MESO's Income towards Parent Company at -$142.2 million in Q2 2023, $18.6 million in Q1 2023, and $24.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Mesoblast 19.81 Bn 19.68 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -142.24 Mn
Mar 31, 2023 18.65 Mn
Dec 31, 2022 24.56 Mn
Sep 30, 2022 16.94 Mn
Jun 30, 2022 -160.86 Mn
Mar 31, 2022 21.29 Mn
Dec 31, 2021 -25.95 Mn
Sep 30, 2021 -22.65 Mn
Jun 30, 2021 -22.06 Mn
Mar 31, 2021 -26.52 Mn
Dec 31, 2020 -25.69 Mn
Sep 30, 2020 -24.54 Mn
Jun 30, 2020 -32.61 Mn
Mar 31, 2020 -15.26 Mn
Dec 31, 2019 -24.58 Mn
Sep 30, 2019 7.42 Mn
Jun 30, 2019 -20.73 Mn
Mar 31, 2019 -24.97 Mn
Dec 31, 2018 -38.31 Mn
Sep 30, 2018 -19.50 Mn